Every year in the U.S., colorectal cancer (CRC) affects more than 136,830 people and is the second leading cause of cancer death. The good news is that it’s also one of the most preventable and, if found early, most treatable forms of cancer. But when it comes to learning about this disease and the steps both health plans and employers can take to keep their populations healthy, there’s no shortage of information out there.
So, we’ve made it easy for you by compiling BioIQ’s most valuable (free) resources and articles – whether you’d like to find out how to raise awareness of this disease amongst your members or employees, launch an at-home testing program, or read up on best practices and guidelines from industry experts, we’ve got you covered.
BioIQ’s Top CRC Resources
CRC screening reduces mortality due to this type of cancer by up to 33 percent and last year alone, BioIQ screened over 250,000 people by partnering with health plans and employers to distribute easy-to-use, at-home test kits. BioIQ’s Chief Medical Officer Josh Sclar, MD, MPH, explains why our CRC testing programs are a great example of high-impact prevention at scale.
BioIQ offers the only comprehensive at-home CRC screening program. We coordinate everything from targeted communications to processing and sharing results, so you can focus on connecting at-risk individuals with the next steps in care. View the infographic to learn how a BioIQ at-home screening program works.
In an exclusive Q&A, Ian Kahn, a Health Systems Manager for the American Cancer Society, discusses the importance of early detection for both employers and their employees, as well as his recommendations for breaking down common barriers to CRC screening and which testing methods the ACS recommends. Read the interview.
The U.S. Multi-Society Task Force, an expert panel comprised of three renowned gastroenterology groups, recently released new CRC screening guidelines that emphasize the importance of FIT testing. Get the details.
In a guest article for Gastroenterology & Endoscopy News, BioIQ’s Chief Medical Officer Josh Sclar offers insight into what gastroenterologists need to know about running effective CRC screening programs. Read the article.
With regular screening, CRC can be prevented through the detection and removal of precancerous polyps. Our 30-minute, on-demand webinar outlines how screening can help save lives, reduce healthcare costs and achieve the National Colorectal Cancer Roundtable (NCCRT) 80% by 2018 initiative. Watch the webinar.
Screening for CRC is important because it can detect cancer in people who are not exhibiting symptoms. Screening rates have increased in recent years, but only 65 percent of U.S. adults were up-to-date with colorectal cancer screening in 2012. Don’t let these common myths become barriers between your population and these potentially life-saving screenings. Read the blog post.
To learn how your organization can implement a CRC screening program and improve the health of your population, contact BioIQ at (888) 818-1594 or email@example.com.